Martine Escoffre-Barbe Selected Research

Martine Escoffre-Barbe Research Topics

Disease

14	Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia) 03/2024 - 02/2011
13	BCR-ABL Positive Chronic Myelogenous Leukemia (Chronic Myelogenous Leukemia) 05/2024 - 02/2014
12	Multiple Myeloma 11/2023 - 03/2013
9	Philadelphia Chromosome 11/2018 - 02/2011
3	Neoplasms (Cancer) 01/2022 - 05/2005
3	Disease Progression 10/2021 - 06/2015
3	Neutropenia 10/2021 - 02/2011
2	Residual Neoplasm 11/2023 - 01/2022
2	Hypertension (High Blood Pressure) 10/2021 - 11/2018
2	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 02/2017 - 06/2010
2	Hypersensitivity (Allergy) 09/2016 - 09/2015
2	Cardiovascular Diseases (Cardiovascular Disease) 02/2016 - 02/2011
2	Thrombocytopenia (Thrombopenia) 11/2014 - 02/2011
1	Renal Insufficiency (Renal Failure) 11/2023
1	Septic Shock (Toxic Shock Syndrome) 10/2021
1	Lymphopenia (Lymphocytopenia) 10/2021
1	Candidiasis (Moniliasis) 01/2021
1	Mycoses (Diseases, Fungus) 01/2021
1	Pleural Effusion (Pleural Effusions) 01/2021
1	Musculoskeletal Pain 11/2019
1	Body Weight (Weight, Body) 02/2017
1	Pathologic Complete Response 02/2017
1	Aplastic Anemia (Anemia, Hypoplastic) 02/2017
1	Non-Hodgkin Lymphoma (Lymphosarcoma) 09/2016
1	Hyperhomocysteinemia 03/2016
1	Venous Thrombosis (Deep-Vein Thrombosis) 11/2015
1	Thrombosis (Thrombus) 11/2015
1	Pancreatitis 09/2015
1	Lymphoma (Lymphomas) 11/2014
1	Hematologic Neoplasms (Hematological Malignancy) 12/2013
1	Precursor T-Cell Lymphoblastic Leukemia-Lymphoma (T-ALL) 11/2011
1	Bacteremia 02/2011
1	Infections 02/2011
1	Myelodysplastic Syndromes (Myelodysplastic Syndrome) 01/2008
1	Follicular Lymphoma (Lymphoma, Small Cleaved Cell, Follicular) 05/2005

Drug/Important Bio-Agent (IBA)

12	Tyrosine Kinase InhibitorsIBA 05/2024 - 02/2014
10	Dexamethasone (Maxidex)FDA LinkGeneric 01/2023 - 03/2013
7	Imatinib Mesylate (Gleevec)FDA Link 03/2024 - 02/2014
5	pomalidomideIBA 01/2023 - 03/2013
5	Bortezomib (Velcade)FDA Link 01/2022 - 03/2013
5	Cyclophosphamide (Cytoxan)FDA LinkGeneric 12/2018 - 11/2002
4	nilotinib FDA Link 03/2024 - 02/2016
4	Doxorubicin (Adriamycin)FDA LinkGeneric 06/2015 - 11/2002
3	Cytarabine (Cytosar-U)FDA LinkGeneric 03/2024 - 06/2010
3	Melphalan (Alkeran)FDA LinkGeneric 11/2023 - 06/2015
3	Thalidomide (Thalomid)FDA Link 10/2021 - 06/2015
3	Lenalidomide (CC 5013)FDA Link 01/2021 - 03/2013
3	Idarubicin (4 Demethoxydaunorubicin)FDA LinkGeneric 02/2017 - 06/2010
3	Methotrexate (Mexate)FDA LinkGeneric 02/2017 - 11/2002
3	Asparaginase (Elspar)FDA Link 09/2016 - 09/2015
2	daratumumabIBA 10/2021 - 01/2019
2	Dasatinib (BMS 354825)FDA Link 01/2021 - 01/2017
2	Phosphotransferases (Kinase)IBA 01/2020 - 01/2017
2	Lomustine (CCNU)FDA Link 02/2017 - 06/2010
2	Vincristine (Oncovin)FDA LinkGeneric 06/2015 - 11/2002
2	Prednisone (Sone)FDA LinkGeneric 06/2015 - 05/2005
1	blinatumomabIBA 01/2022
1	carfilzomibIBA 01/2021
1	Antifungal AgentsIBA 01/2021
1	Protein-Tyrosine Kinases (Tyrosine Kinase)IBA 01/2020
1	Biomarkers (Surrogate Marker)IBA 01/2020
1	ponatinibIBA 11/2018
1	CoagulantsIBA 11/2018
1	Fluorodeoxyglucose F18 (Fludeoxyglucose F 18)FDA Link 09/2017
1	NorethandroloneIBA 02/2017
1	AndrogensIBA 02/2017
1	Mercaptopurine (6 Mercaptopurine)FDA LinkGeneric 02/2017
1	Rituximab (Mabthera)FDA Link 09/2016
1	CD20 AntigensIBA 09/2016
1	coltuximab ravtansineIBA 03/2016
1	Oncogene Proteins (Oncogene Protein)IBA 02/2016
1	Heparin (Liquaemin)FDA LinkGeneric 11/2015
1	AntithrombinsIBA 11/2015
1	Lipase (Acid Lipase)FDA Link 09/2015
1	Telomerase (Telomerase Reverse Transcriptase)IBA 04/2015
1	Cyclin-Dependent Kinase Inhibitor p16IBA 04/2015
1	Prednisolone (Predate)FDA LinkGeneric 11/2014
1	Vindesine (Vindesin)IBA 11/2014
1	YttriumIBA 12/2013
1	epratuzumabIBA 12/2013
1	1,4,7,10-tetraazacyclododecane- 1,4,7,10-tetraacetic acidIBA 12/2013
1	liposomal doxorubicin (Doxil)FDA Link 02/2011
1	Erythropoietin FDA Link 01/2008
1	Granulocyte Colony-Stimulating Factor (G-CSF)IBA 01/2008
1	epoetin betaIBA 01/2008
1	Teniposide (VM 26)FDA Link 05/2005
1	InterferonsIBA 05/2005
1	Vinblastine (Vinblastine Sulfate)FDA Link 11/2002

Therapy/Procedure

14	Therapeutics 11/2023 - 05/2005
6	Drug Therapy (Chemotherapy) 03/2024 - 11/2002
4	Stem Cell Transplantation 11/2023 - 05/2005
3	Transplantation 11/2023 - 05/2005
1	Salvage Therapy 01/2023
1	Immunotherapy 01/2022
1	Splenectomy 01/2021
1	Aftercare (After-Treatment) 01/2018
1	Injections 11/2015
1	Induction Chemotherapy 11/2015
1	Radioimmunotherapy 12/2013
1	Erythrocyte Transfusion 02/2011